Insider Selling: Milestone Scientific Inc. (NYSE:MLSS) Director Sells $100,425.12 in Stock

Milestone Scientific Inc. (NYSE:MLSS) Director Leonard Osser sold 107,984 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the sale, the director now owns 4,606,882 shares in the company, valued at $4,284,400.26. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Leonard Osser also recently made the following trade(s):

• On Wednesday, August 21st, Leonard Osser sold 141,913 shares of Milestone Scientific stock. The stock was sold at an average price of $0.95, for a total value of $134,817.35.

Milestone Scientific Stock Performance

NYSE MLSS opened at $0.79 on Friday. The firm’s fifty day moving average price is $0.94 and its two-hundred day moving average price is $0.82. The stock has a market cap of $61.17 million, a PE ratio of -11.14 and a beta of 1.08. Milestone Scientific Inc. has a fifty-two week low of $0.52 and a fifty-two week high of $1.10.

Milestone Scientific (NYSE:MLSS) last issued its quarterly earnings data on Thursday, August 15th. The company reported ($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%. The firm had revenue of $1.85 million for the quarter.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. StockNews.com assumed coverage on Milestone Scientific in a report on Friday. They set a “hold” rating for the company. Benchmark started coverage on shares of Milestone Scientific in a report on Thursday, October 10th. They issued a “speculative buy” rating and a $1.25 target price for the company.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.